MAPT and neurodegenerative disease: Abnormally phosphorylated tau undergoes misfolding and aggregation, which constitutes a widespread feature among neurodegenerative diseases, including Alzheimer’s disease (AD) and Frontotemporal dementias (FTDs) [7,8].